Drug intelligence / Profile preview

Dexmedetomidine and Salbutamol Combination

Development stage
Discontinued
Lead developer
Orion
Modality
Small Molecules
Administration
Intravenous, Inhalation
01

Overview

The combination of dexmedetomidine and salbutamol appears to be a treatment approach that has been studied for acute asthma management. According to the search results, this combination has been evaluated in clinical trials, particularly for its potential efficacy in treating acute asthma exacerbations in emergency department settings[1][9].\n\n## Drug Information\n\nDexmedetomidine is a selective α2-adrenoreceptor agonist that has sedative, analgesic, anti-inflammatory, and sympatholytic properties[7]. It's primarily used for sedation in intensive care settings and during procedures[3][10]. Salbutamol (also known as albuterol in the US) is a moderately selective beta-2 receptor agonist widely used as a bronchodilator to manage asthma and other chronic obstructive airway diseases[5][6].\n\n## Clinical Evidence\n\nA clinical trial published in 2021 evaluated the efficacy of using dexmedetomidine with salbutamol compared to salbutamol nebulization alone in patients with acute exacerbation of asthma presenting to the emergency department[1]. The study included 60 patients aged 18-55 years with signs of bronchospasm. In the intervention group, dexmedetomidine 0.5 μg/kg was injected intravenously along with three doses of salbutamol nebulization administered over 60 minutes, while the control group received only salbutamol nebulization three times over 60 minutes[1].\n\nThe results showed that the increased mean forced expiratory volume in 1 second and mean peak expiratory flow rate were similar in both groups during treatment, indicating no significant difference in efficacy. However, the mean systolic and diastolic blood pressure recorded at 40 and 60 minutes were significantly lower in the dexmedetomidine group[1].\n\nThe study concluded that the administration of dexmedetomidine in addition to standard salbutamol treatment had no beneficial effect in patients with acute asthma attacks and merely caused hypotension in patients[1].\n\n## Pediatric Use\n\nThere is also mention of dexmedetomidine with continuous salbutamol inhalation being used in the treatment of pediatric near-fatal asthma, though detailed information on this application is limited in the search results[2][4].\n\n## Drug Interactions\n\nThe search results indicate that dexmedetomidine and salbutamol may have some interaction effects. Specifically, the risk or severity of hypertension can be increased when dexmedetomidine is combined with salbutamol[3][5]. This interaction should be considered when administering these medications together.\n\n## Safety Considerations\n\nWhen using dexmedetomidine with salbutamol, healthcare providers should be aware of potential cardiovascular effects. The clinical trial mentioned above found that the combination caused hypotension in patients[1]. Additionally, dexmedetomidine may decrease the excretion rate of other drugs, potentially resulting in higher serum levels[3].\n\nIn summary, while the combination of dexmedetomidine and salbutamol has been studied for acute asthma management, current evidence suggests it may not provide additional benefits over salbutamol alone and may increase the risk of hypotension and other cardiovascular effects.

Other names
dexmedetomidine with salbutamoldexmedetomidine + albuterol
02

Targets

ADRA2A (α2A)ADRB2 (β2)

Beyond the preview

Go deeper on Dexmedetomidine and Salbutamol Combination.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dexmedetomidine and Salbutamol Combination.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call